526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827764735930531840 |
|---|---|
| author | Se-Hoon Lee Diego Chowell Eytan Ruppin Cristina Valero Yingying Cao Luc Morris Saugato R Dhruba Tiangen Chang Hannah Sfreddo Seong-Keun Yoo |
| author_facet | Se-Hoon Lee Diego Chowell Eytan Ruppin Cristina Valero Yingying Cao Luc Morris Saugato R Dhruba Tiangen Chang Hannah Sfreddo Seong-Keun Yoo |
| author_sort | Se-Hoon Lee |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:08:34Z |
| format | Article |
| id | doaj.art-8f8625a6d75f440295d5913d64dd051f |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:08:34Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-8f8625a6d75f440295d5913d64dd051f2023-11-12T09:30:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0526526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic featuresSe-Hoon Lee0Diego Chowell1Eytan Ruppin2Cristina Valero3Yingying Cao4Luc Morris5Saugato R Dhruba6Tiangen Chang7Hannah Sfreddo8Seong-Keun Yoo9Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, The Republic of KoreaAff11 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center New York NY USA1National Institutes of Health, Bethesda, MD, USA1 Rheumatology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain1National Institutes of Health, Bethesda, MD, USAMemorial Sloan Kettering Cancer Center, New York, NY, USANational Cancer Institute, National Institutes of Health, Bethesda, MD, USA1National Institutes of Health, Bethesda, MD, USA2Memorial Sloan Kettering Cancer Center, New York, NY, USA2Memorial Sloan Kettering Cancer Center, New York, NY, USA |
| spellingShingle | Se-Hoon Lee Diego Chowell Eytan Ruppin Cristina Valero Yingying Cao Luc Morris Saugato R Dhruba Tiangen Chang Hannah Sfreddo Seong-Keun Yoo 526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features Journal for ImmunoTherapy of Cancer |
| title | 526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features |
| title_full | 526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features |
| title_fullStr | 526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features |
| title_full_unstemmed | 526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features |
| title_short | 526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features |
| title_sort | 526 robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical pathologic and genomic features |
| work_keys_str_mv | AT sehoonlee 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT diegochowell 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT eytanruppin 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT cristinavalero 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT yingyingcao 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT lucmorris 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT saugatordhruba 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT tiangenchang 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT hannahsfreddo 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures AT seongkeunyoo 526robustpredictionofpatientoutcomeswithimmunecheckpointblockadetherapyforcancerusingcommonclinicalpathologicandgenomicfeatures |